Atlas Trials

A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects

Clinical trial NCT02111317 · COMPLETED

Trial details

NCT number
NCT02111317
Sponsor
Astellas Pharma Global Development, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy SubjectsPharmacokinetics of ASP015K
Start date
2013-10-01
Primary completion
2013-11-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.